Description
The health of the life science tools industry is directly tied to the annual investments in research and development made by governments, private industry and investors. The economic climate, political pressures, societal needs and technology will all affect the outlook for funding life science research, drug discovery and development in 2017. Despite an improving global economy, the life science industry begins 2017 in state of uncertainty. We have just released Laboratory Budgets and Sources of Funding in 2017: The Market Outlook for the United States, Europe and Asia to help provide clarity in these uncertain times. The report is based on a survey of more than 1,000 life scientists who answered a detailed questionnaire about their budget and spending plans for 2017.
This unique report details the percent of lab budgets allocated for instrumentation and consumables. Spending for both instrumentation and consumables is then presented for 10 broad sub-categories including:
- Cell based analysis
- Genome analysis
- Protein analysis
- General lab equipment
- Cell-based analysis kits and reagents
- Genome analysis kits and reagents
- Protein purification and separation kits and reagents
- Live animals
- General laboratory chemicals, plasticware, glassware and disposables
The data is presented by market segment and region. The insights contained in this report will enable senior management to forecast demand, fine-tune projections, and set goals and allocations for 2017.
Please download the complimentary Report Brochure to review the detailed objectives, table of contents, and sample data.
To purchase this report and/or for any interest in region specific report information, please contact:
Madeline Kalicka
Content Marketing Associate
BioInformatics LLC
703.778.3080 ext. 19
reports@gene2drug.com
www.gene2drug.com
